Hunter C. Smith - 07 Jul 2025 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Financial Officer
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Hunter C. Smith
Issuer symbol
RYTM
Transactions as of
07 Jul 2025
Net transactions value
+$48,064
Form type
4
Filing time
08 Jul 2025, 16:30:14 UTC
Previous filing
03 Jun 2025
Next filing
11 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Hunter C Chief Financial Officer C/O RHYTHM PHARMACEUTICALS, INC., 222 BERKELEY STREET, 12TH FLOOR, BOSTON /s/ Stephen Vander Stoep, attorney-in-fact for Hunter C. Smith 08 Jul 2025 0001636385

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise $48,064 +6,986 +6.4% $6.88 116,915 07 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Options (Right to Buy) Options Exercise $0 -6,986 -9% $0.000000 70,208 07 Jul 2025 Common Stock 6,986 $6.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.